EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Maravai LifeSciences Holdings, Inc. (MRVI) had EBIT Margin of -115.89% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$185.74M |
|
$-130.77M |
|
$151.75M |
|
$33.99M |
|
$401.01M |
|
$-215.27M |
|
$-19.71M |
|
$-234.97M |
|
$-234.97M |
|
$-230.76M |
|
$-230.76M |
|
$-230.76M |
|
$-230.76M |
|
$-215.27M |
|
$-153.14M |
|
144.36M |
|
144.36M |
|
$-0.90 |
|
$-0.90 |
|
| Balance Sheet Financials | |
$296.25M |
|
$151.48M |
|
$474.33M |
|
$770.58M |
|
$44.92M |
|
$316.47M |
|
$352.95M |
|
$397.87M |
|
$372.71M |
|
$91.74M |
|
$372.71M |
|
256.01M |
|
| Cash Flow Statement Financials | |
$-57.57M |
|
$-31.41M |
|
$-16.50M |
|
$322.40M |
|
$216.89M |
|
$-105.51M |
|
$30.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.60 |
|
-- |
|
-- |
|
0.46 |
|
0.86 |
|
18.30% |
|
-115.89% |
|
|
EBIT Margin |
-115.89% |
-82.45% |
|
-126.50% |
|
-70.41% |
|
$-70.72M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
3.75 |
|
7.28 |
|
50.11 |
|
-61.91% |
|
-251.54% |
|
-29.95% |
|
-33.48% |
|
$1.46 |
|
$-0.49 |
|
$-0.40 |
|